Primary information |
---|
CancerPPD ID | 2923 |
PMID | 21849092 |
YEAR | 2011 |
SEQUENCE | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK |
LENGTH | 32 |
NAME | Transferrin receptor (TfR)-lytic hybrid peptide |
C-ter Modification | Free |
N-ter Modification | Free |
Linear/Cyclic | Linear |
L/D/Mix | Mix |
Non-Natural | None |
NATURE | Anticancer |
ACTIVITY | IC50= 6.2 µM |
SOURCE | Transferrin receptor (TfR) |
Cancer Type | Prostate Cancer |
ASSAY | WST-1 assay |
Patent ID | None |
Tissue | Prostate |
CELL LINE | LNCaP |
TEST TIME | 72-h |
Secondary information |
---|
STRUCTURE | |
DSSP states | CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC |
SMILES | N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O |
External Links |
---|
PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
NA | NA | NA | NA | >tr_Q95VE8_Q95VE8_MUSDOCecropinOS=MuscadomesticaGN=Cep1PE=3SV=1 | NA | NA | NA |
|